Keywords: ct, bis-platinate, drugs, show, activity, against, resistant
CT's bis-platinate drugs show activity against resistant tumors
Article | 05 November 2007
USA-based Cell Therapeutics says that preclinical data demonstrate that its bis-platinate drug candidates, CT-47613 and CT-47609, can kill tumors resistant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
